CY1112031T1 - Υποκατεστημενη 5-φαινυλο-3,6-διυδρο-2-οξο-6η-[1,3,4]θειαδιαζινη - Google Patents
Υποκατεστημενη 5-φαινυλο-3,6-διυδρο-2-οξο-6η-[1,3,4]θειαδιαζινηInfo
- Publication number
- CY1112031T1 CY1112031T1 CY20111101025T CY111101025T CY1112031T1 CY 1112031 T1 CY1112031 T1 CY 1112031T1 CY 20111101025 T CY20111101025 T CY 20111101025T CY 111101025 T CY111101025 T CY 111101025T CY 1112031 T1 CY1112031 T1 CY 1112031T1
- Authority
- CY
- Cyprus
- Prior art keywords
- thiadiazine
- dihydro
- oxo
- phenyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ενώσεις τύπου (I), όπου τα R1 , R2 , m, Q και Β έχουν τις σημασίες που παρατίθενται στην αξίωση 1, είναι αναστολείς κινάσης τυροσίνης, και συγκεκριμένα της κινάσης Met, και μπορούν μεταξύ άλλων να χρησιμοποιηθούν για τη θεραπεία των όγκων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005055354A DE102005055354A1 (de) | 2005-11-21 | 2005-11-21 | Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine |
EP06806537A EP1951697B1 (de) | 2005-11-21 | 2006-10-25 | Substituierte 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazine |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112031T1 true CY1112031T1 (el) | 2015-11-04 |
Family
ID=37734761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101025T CY1112031T1 (el) | 2005-11-21 | 2011-10-27 | Υποκατεστημενη 5-φαινυλο-3,6-διυδρο-2-οξο-6η-[1,3,4]θειαδιαζινη |
Country Status (21)
Country | Link |
---|---|
US (1) | US7902186B2 (el) |
EP (1) | EP1951697B1 (el) |
JP (1) | JP5334586B2 (el) |
KR (1) | KR101424825B1 (el) |
CN (1) | CN101312956A (el) |
AR (1) | AR058205A1 (el) |
AT (1) | ATE517878T1 (el) |
AU (1) | AU2006314873B2 (el) |
BR (1) | BRPI0618806A2 (el) |
CA (1) | CA2630202C (el) |
CY (1) | CY1112031T1 (el) |
DE (1) | DE102005055354A1 (el) |
DK (1) | DK1951697T3 (el) |
EA (1) | EA015352B1 (el) |
ES (1) | ES2368001T3 (el) |
IL (1) | IL191360A (el) |
PL (1) | PL1951697T3 (el) |
PT (1) | PT1951697E (el) |
SI (1) | SI1951697T1 (el) |
WO (1) | WO2007057092A1 (el) |
ZA (1) | ZA200805406B (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005055355A1 (de) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007026341A1 (de) * | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007041115A1 (de) * | 2007-08-30 | 2009-03-05 | Merck Patent Gmbh | Thiadiazinonderivate |
DE102007061963A1 (de) * | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
DE102008062826A1 (de) | 2008-12-23 | 2010-07-01 | Merck Patent Gmbh | Pyridazinonderivate |
DE102009003975A1 (de) * | 2009-01-07 | 2010-07-08 | Merck Patent Gmbh | Benzothiazolonderivate |
RU2458060C2 (ru) * | 2009-05-22 | 2012-08-10 | Государственное образовательное учреждение высшего профессионального образования "Уральский государственный технический университет - УПИ имени первого Президента России Б.Н. Ельцина" | 5-(4'-гидроксифенил)- и 5-(2',5'-дигидроксифенил)-6н-1,3,4-тиадиазин-2-амины, гидрогалагениды, ингибирующие агрегацию тромбоцитов при внутривенном введении |
CN111454232B (zh) * | 2020-05-30 | 2021-11-23 | 南方医科大学 | 一种1,3,4-噻二嗪类化合物及其应用 |
US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19502699A1 (de) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | Arylalkyl-thiadiazinone |
DE19533975A1 (de) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
GB9525262D0 (en) * | 1995-12-11 | 1996-02-07 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
DE19604388A1 (de) * | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | Arylalkyl-diazinone |
EP1212296B9 (en) * | 1999-08-27 | 2006-05-10 | Sugen, Inc. | Phosphate mimics and methods of treatment using phosphatase inhibitors |
DE10150517A1 (de) * | 2001-10-12 | 2003-04-17 | Merck Patent Gmbh | Verwendung von Phosphodiesterase IV-Inhibitoren |
CA2462525A1 (en) * | 2001-10-31 | 2003-05-08 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Type 4 phosphodiesterase inhibitors and uses thereof |
DE60237637D1 (de) * | 2001-12-11 | 2010-10-21 | Fujifilm Corp | Thiadiazolinderivate zur Krebsbehandlung |
DE102005055355A1 (de) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
-
2005
- 2005-11-21 DE DE102005055354A patent/DE102005055354A1/de not_active Withdrawn
-
2006
- 2006-10-25 SI SI200631094T patent/SI1951697T1/sl unknown
- 2006-10-25 US US12/094,542 patent/US7902186B2/en not_active Expired - Fee Related
- 2006-10-25 BR BRPI0618806-0A patent/BRPI0618806A2/pt not_active Application Discontinuation
- 2006-10-25 ES ES06806537T patent/ES2368001T3/es active Active
- 2006-10-25 DK DK06806537.4T patent/DK1951697T3/da active
- 2006-10-25 CA CA2630202A patent/CA2630202C/en not_active Expired - Fee Related
- 2006-10-25 AU AU2006314873A patent/AU2006314873B2/en not_active Ceased
- 2006-10-25 CN CNA2006800434108A patent/CN101312956A/zh active Pending
- 2006-10-25 EP EP06806537A patent/EP1951697B1/de active Active
- 2006-10-25 KR KR1020087014967A patent/KR101424825B1/ko active IP Right Grant
- 2006-10-25 JP JP2008540479A patent/JP5334586B2/ja not_active Expired - Fee Related
- 2006-10-25 PL PL06806537T patent/PL1951697T3/pl unknown
- 2006-10-25 WO PCT/EP2006/010285 patent/WO2007057092A1/de active Application Filing
- 2006-10-25 PT PT06806537T patent/PT1951697E/pt unknown
- 2006-10-25 AT AT06806537T patent/ATE517878T1/de active
- 2006-10-25 EA EA200801365A patent/EA015352B1/ru not_active IP Right Cessation
- 2006-11-21 AR ARP060105082A patent/AR058205A1/es not_active Application Discontinuation
-
2008
- 2008-05-12 IL IL191360A patent/IL191360A/en not_active IP Right Cessation
- 2008-06-20 ZA ZA200805406A patent/ZA200805406B/xx unknown
-
2011
- 2011-10-27 CY CY20111101025T patent/CY1112031T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006314873A1 (en) | 2007-05-24 |
US7902186B2 (en) | 2011-03-08 |
DE102005055354A1 (de) | 2007-10-31 |
CA2630202A1 (en) | 2007-05-24 |
EA200801365A1 (ru) | 2008-10-30 |
KR20080070763A (ko) | 2008-07-30 |
BRPI0618806A2 (pt) | 2011-09-13 |
WO2007057092A1 (de) | 2007-05-24 |
PL1951697T3 (pl) | 2011-11-30 |
SI1951697T1 (sl) | 2011-09-30 |
PT1951697E (pt) | 2011-11-04 |
CA2630202C (en) | 2015-03-31 |
ATE517878T1 (de) | 2011-08-15 |
AU2006314873B2 (en) | 2011-12-08 |
IL191360A (en) | 2013-10-31 |
EP1951697A1 (de) | 2008-08-06 |
JP2009516657A (ja) | 2009-04-23 |
ZA200805406B (en) | 2009-11-25 |
EP1951697B1 (de) | 2011-07-27 |
ES2368001T3 (es) | 2011-11-11 |
JP5334586B2 (ja) | 2013-11-06 |
CN101312956A (zh) | 2008-11-26 |
EA015352B1 (ru) | 2011-06-30 |
US20080318936A1 (en) | 2008-12-25 |
DK1951697T3 (da) | 2011-09-26 |
AR058205A1 (es) | 2008-01-23 |
KR101424825B1 (ko) | 2014-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112031T1 (el) | Υποκατεστημενη 5-φαινυλο-3,6-διυδρο-2-οξο-6η-[1,3,4]θειαδιαζινη | |
CY1118498T1 (el) | Παραγωγα πυριδαζινονης | |
CY1116191T1 (el) | Παραγωγα πυριδαζινονης | |
CY1111556T1 (el) | Παραγωγα 2-βενζυλοπυριδαζινονης ως αναστολεις μετ-κινασης | |
CY1112235T1 (el) | Παραγωγα 3,6-διυδρο-2-οξο-6η-(1,3,4)-θειαδιαζινης | |
CY1114574T1 (el) | Παραγωγα πιπεριδινης και πιπεραζινης για τη θεραπεια ογκων | |
ECSP088598A (es) | Derivados de piridazinona | |
CY1113443T1 (el) | Παραγωγα πυριδαζινονης | |
CY1120260T1 (el) | Ενωσεις υποκατεστημενης πυραζολο [1,5-] πυριμιδινης ως αναστολεις κινασης trk | |
CY1113698T1 (el) | Παραγωγα πυριδαζινονης | |
EA200901601A1 (ru) | Производные пиридазинона | |
WO2005054246A3 (de) | Aminderivate mit tyrosinkinase hemmender wirkung | |
CY1108032T1 (el) | Πυρρολο υποκατεστημενης 2-ινδολινονης αναστολεις κινασης πρωτεϊνης | |
EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
MX2008002104A (es) | Derivados de 1-acildihidropirazol. | |
BRPI0415760A (pt) | derivados de benzimidazolila | |
IS7721A (is) | Píperidín-pýrídasón og þalasón sem PDE4 hemlar | |
ATE471324T1 (de) | Triazolophthalazine | |
AU2005293821A1 (en) | N,N'-dithenylurea derivatives used in the form of kinase inhibitors | |
EA201000550A1 (ru) | Производные тиазола | |
EA200901603A1 (ru) | Арил-эфирные производные пиридазинона | |
BR0209149A (pt) | Ftalazinonas | |
TW200700358A (en) | Organic compounds | |
BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
EA200300478A1 (ru) | Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции |